Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Tripo AI ~$445M Series BExcalipoint Therapeutics $27.7M Seed+Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Tripo AI ~$445M Series BExcalipoint Therapeutics $27.7M Seed+New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Sunrise CN¥2B Equity financingiSpace China CN¥5B Series D++New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Math Magic Undisclosed Series A+LatentVerse Undisclosed SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Math Magic Undisclosed Series A+Moonshot AI $2B Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
Siengine Undisclosed Series C+iSpace China CN¥5B Series D++New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Chang Guang Satellite Technology ~CN¥5B Equity financingBYD Semiconductor CN¥800M Series A+ strategic capital increaseNew companies 1 · Follow-on 0
Stages: Seed 2
Delta Intelligence Undisclosed Seed+Delta Intelligence Undisclosed AngelNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Delta Intelligence Undisclosed AngelSyneron Bio $150M Series BNew companies 1 · Follow-on 0
Stages: Seed 2
Delta Intelligence Undisclosed Seed+Delta Intelligence Undisclosed AngelNew companies 1 · Follow-on 1
Stages: Series B 1, Undisclosed 1
SignalPlus $50M Series B1SignalPlus $40M StrategicNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Full-Life Technologies $150M Series D+DebtOricell Therapeutics $110M Pre-IPONew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Vivacta Biotechnology $50M Series A+Syneron Bio $150M Series BNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Syneron Bio $150M Series BExcalipoint Therapeutics $27.7M Seed+“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.